v1
An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer.
Identifier:nobleid.org/w1/20260515/BA20FBC6
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/BA20FBC6)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims